Young scientist Jeffrey Statten, fueled by the tragic loss of his best friend Charlie Wickers to leukemia, dedicates his life to developing a universal cancer cure he calls "Charlie's syrup." At a high-profile science exposition, Jeffrey unveils his cure to a captivated audience, including powerful investors from big pharmaceutical corporations. As he showcases the drug's effects on volunteer cancer patients, a prominent pharmaceutical billionaire named John Langdon takes interest, inviting Jeffrey to discuss a potential partnership. However, their meeting reveals Langdon's true intentions and the dangerous stakes surrounding Jeffrey's discovery.